Jefferies Cuts RLI as Stock Runs Past Analyst Targets
RLI Corp. has beaten Wall Street earnings estimates in each of the four most recent quarters, yet Jefferies has downgraded the specialty insurer on valuation concerns and the stock at $63.35 already t
Jefferies Cuts RLI as Stock Runs Past Analyst Targets
NEW YORK, September 3 —
RLI Corp. (RLI) has delivered four consecutive earnings beats, most recently posting $0.83 against a $0.72 consensus, yet the track record appears fully priced. The specialty insurer's shares at $63.35 already exceed the analyst consensus target of $60.50, prompting Jefferies to downgrade on valuation as short sellers load up against the premium.
- Q2 2026 EPS of $0.83 beat the $0.72 consensus by 15.3%, per an 8-K filed July 22.
- Trailing-twelve-month revenue of $1.97 billion growing 15.2% year over year; free cash flow of $316 million.
- Short interest at 9.6% of the float; shares trade at 23.5x forward earnings, above the sell-side consensus.
Consistent Is the Easy Part
RLI Corp. writes the kind of insurance most carriers avoid: commercial excess liability, D&O coverage for exposed executives, errors and omissions policies for small design and tech firms, and commercial auto for long-haul truckers. That selective underwriting has produced four consecutive quarterly beats, with surprise margins ranging from 6.4% to 18.6% over the trailing year. The Q2 combined ratio drew strong analyst commentary even as some maintained cautious forward forecasts. The pattern is real. Whether a 23.5x forward multiple, which investors can stress-test at the DCF calculator, has already absorbed every future iteration of it is the harder question.
Valuation Has Lapped the Street
When a stock trades above the analyst consensus target, the margin-of-safety calculation is already negative. At $63.35 against a $60.50 consensus target, RLI shares have run past the level where the average sell-side analyst sees fair value. Jefferies formalized that gap with a downgrade on valuation concerns roughly nine days ago. Short sellers have taken notice: 9.6% of the float sits short, a level that reflects real carrying costs and genuine conviction about the downside. Two director or officer change filings, an 8-K on July 15 and another on June 25, add organizational uncertainty at precisely the moment when the multiple leaves no room for error.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| RLI | $5.8B | 23.5x | -6.5% |
| SIGI | $5.5B | 10.5x | +12.5% |
| RNR | $13.8B | 8.1x | +34.8% |
| SCL | $1.4B | 16.8x | +24.1% |
| CTBI | $1.4B | 11.9x | +28.7% |
| CBSH | $8.3B | 12.7x | -2.7% |
What Q3 Has to Prove
RLI's trailing revenue of $1.97 billion growing at 15.2% and free cash flow of $316 million show the underwriting engine is generating real returns. The bull case is that a specialty insurer with this underwriting record and consistent beat margins is worth paying up for. But the beat sequence ran 18.6%, 16.0%, 6.4%, then 15.3%, with estimates resetting higher after every print, and the fifth consecutive beat at a ratcheted-up bar is harder to deliver. A Q3 result that barely clears consensus ends the premium case. Run the free RLI Corp. deep-dive before that print.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
RLI Corp. has beaten Wall Street earnings estimates in each of the four most recent quarters, yet Jefferies has downgraded the specialty insurer on valuation concerns and the stock at $63.35 already trades above the analyst consensus price target of $60.50. The market is pricing RLI as though the outperformance can only continue — a bet that a 9.6% short interest in the float suggests a meaningful cohort of investors is willing to take the other side of.
Sources & Filings